Trial Opens In Glaxo's Lamictal Patent Suit
The trial, in the U.S. District Court for the U.S. District of New Jersey, is expected to last between five and seven days. A decision in the case is not expected until much later in the year.
Last July, Chief Judge John W. Bissell of the District of New Jersey granted summary judgment in favor of...
To view the full article, register now.